Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...

The rapid evolution of HIV under antiretroviral pressure necessitates ongoing surveillance of drug resistance mutations. Next-generation sequencing (NGS) has emerged as a transformative technology in ...

According to Nova One Advisor, the global next-generation sequencing market size is calculated at USD 17.37 billion in 2026 ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue to witness sequencer throughput expansion with systems like the Illumina ...

Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene therapies while helping scientists to streamline quality-control processes with a ...

BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation ...

Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...

According to MarketsandMarkets™, the Next-Generation Sequencing Market is projected to grow from about USD 14.94 billion in ...